Healthcare and life science consultancy Lexica has appointed Michèle Wheeler as director of international health and life sciences.
One Nucleus: Linda Summerton
One Nucleus, a membership organisation for life sciences and healthcare companies, has announced the appointment of Linda Summerton as a director.
Summerton is chief executive of Immodulon Therapeutics and a senior partner with TranScrip Partners. She previously worked for 18 years at AstraZeneca, and brings 25 years’ experience in the global pharmaceutical industry.
Chair of One Nucleus Jon Green commented: “Linda is a great addition to the team. She has a deep understanding of the needs of One Nucleus members, and this coupled with her current interests, particularly as CEO of a growing biotech company make her an ideal director for One Nucleus.”
Summerton said: “These are challenging times for life sciences and healthcare companies and One Nucleus is extremely well placed to support the sector. I am delighted to have been asked to join the board and look forward to bringing my experience to the table, to support the team and assist One Nucleus members.”
The Cambridge-based not-for-profit was established in 1997.
Latest Executive Moves
TMC Pharma Services, a global product development and clinical research organisation has appointed Simon Estcourt as chief executive.
PharmaHealthcare Homes has appointed Martin Hill as operations director of its Manorcourt Homecare and Live-in care services.
Social care